Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stolk-engelaar, V. M. M.
Right arrow Articles by Hoogkamp-Korstanje, J. A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stolk-engelaar, V. M. M.
Right arrow Articles by Hoogkamp-Korstanje, J. A. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1995) 36, 839-843
© 1995 The British Society for Antimicrobial Chemotherapy

in-brief

In-vitro antimicrobial susceptibility of Yersinia enterocolitica isolates from stools of patients in The Netherlands from 1982–1991

Virginia M. M. Stolk-engelaar*, Jacques F. G. M. Meis, Janet A. Mulder, Frans L. A. Loeffen and Jacomina A. A. Hoogkamp-Korstanje

Department of Medical Microbiology, University Hospital Nijmegen P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Received 20 January 1995; returned 8 March 1995; accepted 12 June 1995

*Phone: + 31-(80)-614356; Fax: +31-(80)-540216

The MICs of 24 antimicrobial agents were determined for 335 strains of Yersinia enterocolitica isolated from faeces in the Netherlands during 1982–1991. The isolates belonged to biotypes 1A, 1B, 2, 3, 4 and to serotypes 03, O5.27, O6.3, O7.8, 08, O9. Almost all strains were susceptible to piperacillin, piperacillin/tazobactam, imipenem, all cephalosporins except cefazolin, the aminoglycosides, quinolones, co-trimoxazole, doxycycline and chloramphenicol but resistant to amoxycillin, co-amoxiclav and macrolides. No association was observed between susceptibility patterns, biotype or serotype nor were there marked changes in the susceptibilty during the last decade. The agents traditionally used to treat human infection, including co-trimoxazole, doxycycline and chloramphenicol may remain drugs of first choice.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Med MicrobiolHome page
I. STOCK, P. HEISIG, and B. WIEDEMANN
{beta}-Lactamase expression in Yersinia enterocolitica biovars 1A, 1B and 3
J. Med. Microbiol., May 1, 2000; 49(5): 403 - 408.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Grant, V. Bennett-Wood, and R. M. Robins-Browne
Characterization of the Interaction between Yersinia enterocolitica Biotype 1A and Phagocytes and Epithelial Cells In Vitro
Infect. Immun., September 1, 1999; 67(9): 4367 - 4375.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. Stock and B. Wiedemann
An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database
J. Antimicrob. Chemother., January 1, 1999; 43(1): 37 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Grant, V. Bennett-Wood, and R. M. Robins-Browne
Identification of Virulence-Associated Characteristics in Clinical Isolates of Yersinia enterocolitica Lacking Classical Virulence Markers
Infect. Immun., March 1, 1998; 66(3): 1113 - 1120.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.